Bioengineering heart muscle: A paradigm for regenerative medicine

Annual Review of Biomedical Engineering

Volumn 13, Issue , 2011, Pages 245-267

  Vunjak Novakovic, Gordana ^a   Lui, Kathy O ^b,c   Tandon, Nina ^a   Chien, Kenneth R ^b,c  

^a Fu Foundation School of Engineering and Applied Science   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Harvard University   (United States)

Author keywords

Bioreactor; Clinical translation; Heart regeneration; Stem cells; Tissue engineering

Indexed keywords

BIOLOGICALLY INSPIRED; CLINICAL REALITY; CLINICAL TRANSLATION; HEART GRAFT; HEART MUSCLES; HUMAN HEART; HUMAN TISSUES; INTERDISCIPLINARY RESEARCH; MEDICAL DEVICES; RECENT PROGRESS; REGENERATIVE MEDICINE; STEM CELL SCIENCE; TISSUE-ENGINEERED HEART;

MUSCLE; STEM CELLS; TISSUE ENGINEERING;

HEART;

TISSUE SCAFFOLD;

ANGIOGENESIS; ARTICLE; BIOENGINEERING; ELECTROSTIMULATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EPICARDIUM; HEART DEVELOPMENT; HEART GRAFT; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART REGENERATION; HUMAN; HYDROGEL; INFLAMMATION; MECHANICAL STIMULATION; MICROENVIRONMENT; NEURAL CREST; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; BIOENGINEERING; CORONARY VESSELS; HEART; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MODELS, ANIMAL; MYOCARDIUM; ORGAN CULTURE TECHNIQUES; REGENERATION; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTS;

EID: 79960485562     PISSN: 15239829     EISSN: 15454274     Source Type: Book Series    
DOI: 10.1146/annurev-bioeng-071910-124701     Document Type: Article

References (117)

1. Severs NJ. 2000. The cardiac muscle cell. BioEssays 22:188-99 (Pubitemid 30092085)
2. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnab́e-Heider F, et al. 2009. Evidence for cardiomyocyte renewal in humans. Science 324:98-102
3. Am. Heart Assoc. 2008. American Heart Association Cardiovascular Disease Statistics. Washington, DC: Am. Heart Assoc.
4. Vunjak-Novakovic G, Tandon N, Godier A, Maidhof R, Marsano A, et al. 2010. Challenges in cardiac tissue engineering. Tissue Eng. Part B Rev. 16:169-87
5. Saltzman WM. 2004. Tissue Engineering: Engineering Principles for the Design of Replacement Organs and Tissues. New York: Oxford Univ. Press
6. Chien KR. 2008. Regenerative medicine and human models of human disease. Nature 453:302-5 (Pubitemid 351693135)
7. Ross R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340:115-26
8. Langer R, Vacanti J. 1993. Tissue engineering. Science 260:920-26 (Pubitemid 23209960)
9. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, et al. 2009. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460:113-17
10. Qyang Y, Martin-Puig S, Chiravuri M, Chen S, Xu H, et al. 2007. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/β-catenin pathway. Cell Stem Cell 1:165-79 (Pubitemid 47224618)
11. Chien KR, Domian IJ, Parker KK. 2008. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 322:1494-97
12. Domian IJ, Chiravuri M, van der Meer P, Feinberg AW, Shi X, et al. 2009. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 326:426-29
13. Au HTH, Cheng I, Chowdhury MF, Radisic M. 2007. Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials 28:4277-93
14. Badylak SF. 2007. The extracellular matrix as a biologic scaffold material. Biomaterials 28:3587-93
15. Chiu LLY, Radisic M, Vunjak-Novakovic G. 2010. Bioactive scaffolds for engineering vascularized cardiac tissues. Macromol. Biosci. 10:1286-301
16. Daley WP, Peters SB, Larsen M. 2008. Extracellular matrix dynamics in development and regenerative medicine. J. Cell Sci. 121:255-64 (Pubitemid 351356696)
17. Engelmayr GC, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE. 2008. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat. Mater. 7:1003-10
18. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang H-Y, et al. 2008. Embryonic cardiomyocytes beat best on amatrix with heart-like elasticity: scar-like rigidity inhibits beating. J. Cell Sci. 121:3794-802
19. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G. 2007. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc. Natl. Acad. Sci. USA 104:11298-303 (Pubitemid 47175135)
20. Gerecht S, Townsend SA, Pressler H, Zhu H, Nijst CLE, et al. 2007. A porous photocurable elastomer for cell encapsulation and culture. Biomaterials 28:4826-35
21. Hunt JA. 2008. Regenerative medicine: materials in a cellular world. Nat. Mater. 7:617-18
22. Lutolf MP, Gilbert PM, Blau HM. 2009. Designingmaterials to direct stem-cell fate. Nature 462:433-41
23. Ott HC, Matthiesen TS, Goh S-K, Black LD, Kren SM, et al. 2008. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14:213-21 (Pubitemid 351214548)
24. Dvir T, Levy O, Shachar M, Granot Y, Cohen S. 2007. Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Eng. 13:2185-93
25. Radisic M, Marsano A, Maidhof R, Wang Y, Vunjak-Novakovic G. 2008. Cardiac tissue engineering using perfusion bioreactor systems. Nat. Protocols 3:719-38 (Pubitemid 351516766)
26. Radisic M, Park H, Shing H, Consi T, Schoen FJ, et al. 2004. From the cover: functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101:18129-34 (Pubitemid 40054085)
27. Radisic M, Yang L, Boublik J, Cohen RJ, Langer R, et al. 2004. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 286:H507-16 (Pubitemid 38140330)
28. Tandon N, Cannizzaro C, Chao P-HG, Maidhof R, Marsano A, et al. 2009. Electrical stimulation systems for cardiac tissue engineering. Nat. Protocols 4:155-73
29. Tandon N, Marsano A, Maidhof R, Numata K, Montouri-Sorrentino C, et al. 2010. Surface-patterned electrode bioreactor for electrical stimulation. Lab Chip 10:692-700
30. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, et al. 1997. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 11:683-94 (Pubitemid 27318285)
31. Kofidis T, Lenz A, Boublik J, AkhyariP,Wachsmann B, et al. 2003. Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials 24:5009-14
32. Radisic M, Park H, Chen F, Salazar-Lazzaro JE, Wang Y, et al. 2006. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng. 12:2077-91
33. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, et al. 2002. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 90:e40-48
34. Zimmermann W-H, Melnychenko I, Wasmeier G, Didie M, Naito H, et al. 2006. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12:452-58
35. Li Z, Wilson KD, Smith B, Kraft DL, Jia F, et al. 2009a. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS ONE 4:e8443
36. Ransohoff K,Wu J. 2010. Advances in cardiovascular molecular imaging for tracking stem cell therapy. Thromb. Haemostasis. 104:13-22
37. Eschenhagen T, ZimmermannWH, Kleber AG. 2006. Electrical coupling of cardiac myocyte cell sheets to the heart. Circ. Res. 98:573-75
38. Shimizu T, Sekine H, Yang J, Isoi Y, Yamato M, et al. 2006. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 20:708-10 (Pubitemid 46671189)
39. Burdick JA, Vunjak-Novakovic G. 2009. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng. Part A 15:205-19
40. DischerDE, Mooney DJ, Zandstra PW. 2009. Growth factors, matrices, and forces combine and control stem cells. Science 324:1673-77
41. Terrovitis JV, Smith RR, Marban E. 2010. Assessment and optimization of cell engraftment after transplantation into the heart. Circ. Res. 106:479-94
42. Vincent SD, BuckinghamME. 2010.Howtomake a heart: the origin and regulation of cardiac progenitor cells. Curr. Top. Dev. Biol. 90:1-41
43. Martin-Puig S,Wang Z, Chien KR. 2008. Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell 2:320-31 (Pubitemid 351455247)
44. James D, Nam HS, Seandel M, Nolan D, Janovitz T, et al. 2010. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFβ inhibition is Id1 dependent. Nat. Biotechnol. 28:161-66
45. Jin S,HanssonEM, Tikka S, Lanner F, SahlgrenC, et al. 2008. Notch signaling regulates platelet-derived growth factor receptor-βexpression in vascular smooth muscle cells. Circ. Res. 102:1483-91
46. Kurpinski K, Lam H, Chu J, Wang A, Kim A, et al. 2010. Transforming growth factor-β and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28:734-42
47. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, et al. 2007. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25:1015-24
48. Tomescot A, Leschik J, Bellamy V, Dubois G, Messas E, et al. 2007. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 25:2200-5 (Pubitemid 47480478)
49. Yoder MC. 2010. Is endothelium the origin of endothelial progenitor cells? Arterioscler. Thromb. Vasc. Biol. 30:1094-103
50. Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, et al. 2009. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc. Res. 81:565-73
51. Penn MS. 2009. Importance of the SDF-1:CXCR4 axis in myocardial repair. Circ. Res. 104:1133-35
52. Wollert KC, DrexlerH. 2010. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat. Rev. Cardiol. 7:204-15
53. Gepstein L, Ding C, Rehemedula D, Wilson EE, Yankelson L, et al. 2010. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 28:2151-61
54. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. 2010. Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 7:30-37
55. vanLaakeLW,vanDonselaar EG,Monshouwer-Kloots J, SchreursC,Passier R, et al. 2010. Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cell. Mol. Life Sci. 67:277-90
56. Liu J, Fu JD, Siu CW, Li RA. 2007. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25:3038-44
57. Vidarsson H, Hyllner J, Sartipy P. 2010. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev. Rep. 6:108-20
58. Hanjaya-Putra D, Gerecht S. 2009. Mending the failing heart with a vascularized cardiac patch. Cell Stem Cell 5:575-76
59. Hughes CC. 2008. Endothelial-stromal interactions in angiogenesis. Curr. Opin. Hematol. 15:204-9 (Pubitemid 351507572)
60. Oyamada N, Itoh H, Sone M, Yamahara K, Miyashita K, et al. 2008. Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J. Transl. Med. 6:54
61. Murry CE, Keller G. 2008. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132:661-80 (Pubitemid 351260059)
62. Polverini PJ, Nor JE, Peters MC,Mooney DJ. 2003. Growth of human blood vessels in severe combined immunodeficient mice. A new in vivo model system of angiogenesis. Methods Mol. Med. 78:161-77
63. Buckingham M, Meilhac S, Zaffran S. 2005. Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 6:826-35
64. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, et al. 2003. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5:877-89 (Pubitemid 37527688)
65. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, et al. 2006. Multipotent embryonic Isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151-65
66. Sun Y, Liang X, Najafi N, Cass M, Lin L, et al. 2007. Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev. Biol. 304:286-96 (Pubitemid 46399697)
67. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, et al. 2005. Postnatal Isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647-53 (Pubitemid 40282999)
68. Olivey HE, Svensson EC. Epicardial-myocardial signaling directing coronary vasculogenesis. Circ. Res. 106:818-32
69. Hutson MR, Kirby ML. 2007. Model systems for the study of heart development and disease: cardiac neural crest and conotruncal malformations. Semin. Cell Dev. Biol. 18:101-10 (Pubitemid 46343796)
70. Red-Horse K, Ueno H, Weissman IL, Krasnow MA. 2010. Coronary arteries form by developmental reprogramming of venous cells. Nature 464:549-53
71. Manner J. 1999. Does the subepicardial mesenchyme contribute myocardioblasts to the myocardium of the chick embryo heart? A quail-chick chimera study tracing the fate of the epicardial primordium. Anat. Rec. 255:212-26 (Pubitemid 29249870)
72. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87:27-45 (Pubitemid 15029925)
73. Chen S, Borowiak M, Fox JL, Maehr R, Osafune K, et al. 2009. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 5:258-65
74. Yamada T, Yang JJ, Ricchiuti NV, Seraydarian MW. 1985. Oxygen consumption of mammalian myocardial cells in culture: measurements in beating cells attached to the substrate of the culture dish. Anal. Biochem. 145:302-7 (Pubitemid 15100959)
75. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. 1992. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86:320-21
76. Bel A, Planat-Bernard V, Saito A, Bonnevie L, Bellamy V, et al. 2010. Composite Cell Sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 122:S118-23
77. Stevens KR, Pabon L, Muskheli V, Murray CE. 2009. Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng. Part A 15:1211-22
78. Robinson KA, Li J, Mathison M, Redkar A, Cui J, et al. 2005. Extracellular matrix scaffold for cardiac repair. Circulation 112:I-135-43
79. ZimmermannW-H, Schneiderbanger K, Schubert P, DidieM,Munzel F, et al. 2002. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90:223-30 (Pubitemid 34627092)
80. Radisic M, Park H, Gerecht S, Cannizzaro C, Langer R, Vunjak-Novakovic G. 2007. Biomimetic approach to cardiac tissue engineering. Philos. Trans. R. Soc. B 362:1357-68
81. RadisicM, Deen W, Langer R, Vunjak-Novakovic G. 2005. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol. Heart Circ. Physiol. 288:H1278-89 (Pubitemid 40270035)
82. Radisic M, Malda J, Epping E, Geng W, Langer R, Vunjak-Novakovic G. 2006. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol. Bioeng. 93:332-43
83. Serena E, Figallo E, Tandon N, Cannizzaro C, Gerecht S, et al. 2009. Electrical stimulation of human embryonic stem cells: Cardiac differentiation and the generation of reactive oxygen species. Exp. Cell Res. 315:3611-19
84. Chiu LLY, Iyer RK, King J-P, Radisic M. 2008. Biphasic electrical field stimulation aids in tissue engineering of multicell-type cardiac organoids. Tissue Eng. Part A doi:10.1089/ten.tea.2007.0244
85. Atluri P, Woo YJ. 2008. Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential. BioDrugs 22:209-22 (Pubitemid 351969829)
86. Martens T, Godier AFG, Parks JJ, Wan LQ, Koeckert MS, et al. 2009. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant. 18:297-304
87. Kumar AH, Caplice NM. 2010. Clinical potential of adult vascular progenitor cells. Arterioscler. Thromb. Vasc. Biol. 30:1080-87
88. Apostolakis S, Lip GY, Shantsila E. 2010. Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc. Res. 85:649-60
89. Kuraitis D, Suuronen EJ, Sellke FW, Ruel M. 2010. The future of regenerating the myocardium. Curr. Opin. Cardiol. 25:575-82
90. Kane NM, Xiao Q, Baker AH, Luo Z, Xu Q, Emanueli C. 2011. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation). Pharmacol. Ther. 129:29-49
91. Li Z, Han Z, Wu JC. 2009b. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J. Cell. Biochem. 106:194-99
92. Yellon DM, Hausenloy DJ. 2007. Myocardial reperfusion injury. N. Engl. J. Med. 357:1121-35
93. Robey TE, Saiget MK, Reinecke H, Murry CE. 2008. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 45:567-81
94. Sun J, Li SH, Liu SM,WuJ, Weisel RD, et al. 2009. Improvement in cardiac function after bonemarrow cell therapy is associated with an increase in myocardial inflammation. Am. J. Physiol. Heart Circ. Physiol. 296:H43-50
95. Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ. 2003. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc. Res. 58:336-50 (Pubitemid 36570392)
96. van Laake LW, Passier R, Doevendans PA, Mummery CL. 2008. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ. Res. 102:1008-10
97. ZhangM,Methot D, Poppa V, Fujio Y,Walsh K,Murry CE. 2001. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33:907-21 (Pubitemid 32545326)
98. Tang TT, Ding YJ, Liao YH, Yu X, Xiao H, et al. 2010. Defective circulating CD4CD25+Foxp3+CD127low regulatory T-cells in patients with chronic heart failure. Cell. Physiol. Biochem. 25:451-58
99. Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, et al. 2009. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119:2904-12
100. Lui KO, Boyd AS, Cobbold SP, Waldmann H, Fairchild PJ. 2010. A role for regulatory T cells in acceptance of ESC-derived tissues transplanted across an major histocompatibility complex barrier. Stem Cells 28:1905-14
101. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, et al. 2004. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22:1282-89
102. Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, et al. 2005. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111:11-20 (Pubitemid 40070838)
103. Creemers EE, Pinto YM. 2011. Molecular mechanisms that control interstitial fibrosis in the pressureoverloaded heart. Cardiovasc. Res. 89:265-72
104. Leask A. 2010. Potential therapeutic targets for cardiac fibrosis: TGFβ, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 106:1675-80
105. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz-Eldor J, Langer R. 2003. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc. Natl. Acad. Sci. USA 100:12741-46 (Pubitemid 37339969)
106. Yoon SJ, Fang YH, Lim CH, Kim BS, Son HS, et al. 2009. Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel. J. Biomed. Mater. Res. B Appl. Biomater. 91:163-71
107. Singelyn JM, DeQuach JA, Seif-Naraghi SB, Littlefield RB, Schup-Magoffin PJ, Christman KL. 2009. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 30:5409-16
108. Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT. 2005. Custom design of the cardiac microenvironment with biomaterials. Circ. Res. 97:8-15 (Pubitemid 40982317)
109. Gnecchi M, Zhang Z, Ni A, Dzau VJ. 2008. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103:1204-19
110. Hansson EM, Lindsay ME, Chien KR. 2009. Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell 5:364-77
111. Passier R, van Laake LW, Mummery CL. 2008. Stem-cell-based therapy and lessons from the heart. Nature 453:322-29 (Pubitemid 351693138)
112. Laflamme MA, Murry CE. 2005. Regenerating the heart. Nat. Biotechnol. 23:845-56 (Pubitemid 43093128)
113. Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, et al. 2007. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100:263-72 (Pubitemid 46208727)
114. Narmoneva DA, Vukmirovic R, DavisME, Kamm RD, Lee RT. 2004. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 110:962-68 (Pubitemid 39136214)
115. Shen YH, Shoichet MS, Radisic M. 2008. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater. 4:477-89
116. Ratajska A, Ciszek B, Sowi ́ nska A. 2003. Embryonic development of coronary vasculature in rats: Corrosion casting studies. Anat. Rec. Part A 270A:109-16 (Pubitemid 37238368)
117. Segers VFM, Lee RT. 2008. Stem-cell therapy for cardiac disease. Nature 451:937-42 (Pubitemid 351301749)